Related Experiment Video
Updated: May 22, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
[Pluripotent stem cells for cell replacement therapy of diabetes]
1Institut für Klinische Biochemie, Medizinische Hochschule Hannover, Germany. clinbiochem@mh-hannover.de
Abstract:
The use of pluripotent stem cells (PSCs) harbours great potential for a future use in the cell replacement therapy of diabetes mellitus. The in vitro differentiation of human or mouse embryonic stem cells has yielded pancreatic progenitor cells, but not authentic insulin-producing beta cells. Induced pluripotent cells are a class of a pluripotent stem cells potentially suited as a cell source for cell replacement therapy. These patient specific pluripotent cells are generated by reprogramming but unfortunately accumulate genetic and epigenetic errors during reprogramming, precluding their use for therapeutic purposes in humans.
Related Concept Videos
iPS Cell Differentiation
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
